X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
irinotecan/5-fluorouracil/folinic acid (12) 12
index medicus (11) 11
cetuximab (10) 10
1st-line treatment (9) 9
colorectal neoplasms - drug therapy (9) 9
oncology (8) 8
cancer (7) 7
colorectal cancer (7) 7
antineoplastic agents - therapeutic use (6) 6
phase-ii trial (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
camptothecin - analogs & derivatives (5) 5
colorectal neoplasms - pathology (5) 5
treatment outcome (5) 5
antibodies, monoclonal, humanized - therapeutic use (4) 4
clinical trials as topic (4) 4
drug therapy (4) 4
growth-factor receptor (4) 4
initial treatment (4) 4
kras (4) 4
liver neoplasms - secondary (4) 4
metastasis (4) 4
panitumumab (4) 4
plus irinotecan (4) 4
receptor, epidermal growth factor - antagonists & inhibitors (4) 4
receptor, epidermal growth factor - metabolism (4) 4
aged (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic agents - administration & dosage (3) 3
bevacizumab (3) 3
biweekly cetuximab (3) 3
care and treatment (3) 3
cell lung-cancer (3) 3
cetuximab plus irinotecan (3) 3
chemotherapy (3) 3
coefficient of viscosity (3) 3
female (3) 3
fluorouracil - administration & dosage (3) 3
folinic acid (3) 3
hematology, oncology and palliative medicine (3) 3
hepatic resection (3) 3
liver metastases (3) 3
male (3) 3
maximum tolerated dose (3) 3
middle aged (3) 3
monoclonal antibody (3) 3
mutation (3) 3
oxaliplatin (3) 3
portable disposable infusion pump (3) 3
temperature (3) 3
3rd-line therapy (2) 2
5-fluorouracil and irinotecan (2) 2
5-fluorouracil and oxaliplation 6 (2) 2
adult (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - therapeutic use (2) 2
cancer patients (2) 2
cancer therapies (2) 2
colorectal (2) 2
colorectal neoplasms - genetics (2) 2
colorectal neoplasms - surgery (2) 2
combination (2) 2
combined modality therapy (2) 2
dose-response relationship, drug (2) 2
egfr (2) 2
fluorouracil - therapeutic use (2) 2
folfiri (2) 2
folinic acid, 5-fluorouracil and irinotecan (2) 2
folinic acid, 5-fluorouracil and oxaliplation 6 (2) 2
genetic aspects (2) 2
health aspects (2) 2
hepatectomy (2) 2
infusions, intravenous (2) 2
irinotecan (2) 2
leucovorin - administration & dosage (2) 2
leucovorin - therapeutic use (2) 2
liver neoplasms - drug therapy (2) 2
liver neoplasms - surgery (2) 2
metastatic colorectal cancer (2) 2
metastatic colorectal-cancer (2) 2
monoclonal antibodies (2) 2
neoadjuvant chemotherapy (2) 2
neoadjuvant treatment (2) 2
neoplasm metastasis (2) 2
organoplatinum compounds - administration & dosage (2) 2
oxaliplatin-based chemotherapy (2) 2
panitumumab monotherapy (2) 2
pharmacology & pharmacy (2) 2
preoperative chemotherapy (2) 2
proteins (2) 2
receptor, epidermal growth factor - immunology (2) 2
surgery (2) 2
survival rate (2) 2
time factors (2) 2
usage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1065 - 1075
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2009, Volume 21, Issue 7, pp. 1537 - 1545
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 15, pp. 4208 - 4219
Journal Article
STRAHLENTHERAPIE UND ONKOLOGIE, ISSN 0179-7158, 12/2009, Volume 185, Issue 12, pp. 840 - 842
Journal Article
Journal Article
Targeted Oncology, ISSN 1776-2596, 12/2009, Volume 4, Issue 4, pp. 311 - 322
Journal Article
YAKUGAKU ZASSHI, ISSN 0031-6903, 2010, Volume 130, Issue 4, pp. 621 - 627
『緒言』 われわれは, 既報1)において46時間の持続点滴が含まれるレジメン(FOLFOX6, FOLFIRI:Table 1)で携帯型ディスポーザブル注入ポンプ(ニプロ社製シュアーフューザーA:SFS-5-25 32℃条件での生理食塩水での流量5ml/h)を使用した場合に, 薬液の総充填量と点滴時間の関係を調査し,... 
Journal Article